EFFICACY OF PIDOTIMOD IN CHILDREN- A SYSTEMATIC REVIEW
Author(s)
ABSTRACT WITHDRAWN
OBJECTIVES To systematically evaluate the efficacy of pidotimod in children, and provide evidence of evidence-based medicine for clinical treatment. METHODS Databases including Pubmed, The Cochrane Library, EMbase (Ovid), CNKI, CBM, VIP and WanFang Database were searched from inception to January 2018,to collect randomized controlled trials (RCTs) about pidotimod in children.Two reviewers independently screened literature, extracted data, evaluate the quality of included studies,and meta-analysis was performed by RevMan 5.3. RESULTS 318 RCTs involving 27500 children were included. The result of meta-analysis showed that compared with the control group, the pidotimod group could significantly reduce the number of respiratory tract infection[MD=-2.79, 95%CI(-3.12, -2.46),P<0.05],the time of respiratory tract infection[MD=-4.15, 95%CI(-4.72, -3.58),P<0.05], the time of fever[MD=-1.47,95%CI(-1.77,-1.17),P<0.05] in recurrent respiratory tract infection.And pidotimod could reduce the time of fever [MD= -0.25,95%CI(-0.38,-0.11),P<0.05] in mycoplasma pneumoniae pneumonia, the time of fever [RR= 1.163,95%CI(1.043,1.297,P<0.05)] in hand-foot-mouth disease,,incidence of anaphylactoid purpura followed up for 6 months[RR=0.370,95%CI(0.215, 0.636),P<0.05] in anaphylactoid purpura,but there was no significant difference between the pidotimod group and the control group in the incidence of asthma followed up for 1 year[RR= 0.80,95%CI(0.60, 1.06),P>0.05]in asthma. CONCLUSIONS Current evidence shows that,Pidotimod may be effective for respiratory tract infection,asthma,hand-foot-mouth disease,could reduce disease relapse and relieve symptoms related to illness.Due to limited quality included studies more strict designed and multicenter clinical researches are needed to verify the above conclusion.
Conference/Value in Health Info
2019-05, ISPOR 2019, New Orleans, LA, USA
Value in Health, Volume 22, Issue S1 (2019 May)
Code
PIH3
Topic
Clinical Outcomes
Topic Subcategory
Comparative Effectiveness or Efficacy
Disease
Drugs, Multiple Diseases, Pediatrics